Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ohmori

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
Journal of Clinical Pharmacy and Therapeutics|December 17, 2011
CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjectsK Nakamura, K Obayashi, T Araki, et al.
Atherosclerosis|October 5, 2001
Histological and functional analysis of vascular smooth muscle cells in a novel culture system with honeycomb-like structureI Ishii, A Tomizawa, H Kawachi, et al.
International Journal of Oncology|October 18, 2001
Combining transcatheter arterial chemoembolization with percutaneous ethanol injection therapy for small size hepatocellular carcinomaH Okano, K Shiraki, H Inoue, et al.
Therapeutic Drug Monitoring|June 13, 2000
Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysisI Ieiri, H Tainaka, T Morita, et al.
Chirality|January 23, 1999
Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6S Narimatsu, R Kato, T Horie, et al.
Oncology Reports|February 22, 2001
Natural course of cavernous hepatic hemangiomaH Okano, K Shiraki, H Inoue, et al.
Chirality|March 29, 2001
High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosolS Narimatsu, N Kobayashi, K Asaoka, et al.
Anticancer Research|November 20, 2001
Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosisH Okano, K Shiraki, H Inoue, et al.
International Journal of Oncology|July 11, 2001
"Variable echo sign" (ultrasonographical alteration of echogenicity) in cavernous hepatic hemangiomaH Okano, K Shiraki, H Inoue, et al.
Chemico-Biological Interactions|July 21, 2000
Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymesS Narimatsu, N Kobayashi, Y Masubuchi, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
Journal of Clinical Pharmacy and Therapeutics|December 17, 2011
CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjectsK Nakamura, K Obayashi, T Araki, et al.
Atherosclerosis|October 5, 2001
Histological and functional analysis of vascular smooth muscle cells in a novel culture system with honeycomb-like structureI Ishii, A Tomizawa, H Kawachi, et al.
International Journal of Oncology|October 18, 2001
Combining transcatheter arterial chemoembolization with percutaneous ethanol injection therapy for small size hepatocellular carcinomaH Okano, K Shiraki, H Inoue, et al.
Therapeutic Drug Monitoring|June 13, 2000
Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysisI Ieiri, H Tainaka, T Morita, et al.
Chirality|January 23, 1999
Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6S Narimatsu, R Kato, T Horie, et al.
Oncology Reports|February 22, 2001
Natural course of cavernous hepatic hemangiomaH Okano, K Shiraki, H Inoue, et al.
Chirality|March 29, 2001
High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosolS Narimatsu, N Kobayashi, K Asaoka, et al.
Anticancer Research|November 20, 2001
Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosisH Okano, K Shiraki, H Inoue, et al.
International Journal of Oncology|July 11, 2001
"Variable echo sign" (ultrasonographical alteration of echogenicity) in cavernous hepatic hemangiomaH Okano, K Shiraki, H Inoue, et al.
Chemico-Biological Interactions|July 21, 2000
Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymesS Narimatsu, N Kobayashi, Y Masubuchi, et al.
Pageof 31